These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18353923)

  • 1. Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.
    Eslahpazir J; Jenabian MA; Bouhlal H; Hocini H; Carbonneil C; Grésenguet G; Mbopi Kéou FX; LeGoff J; Saïdi H; Requena M; Nasreddine N; de Dieu Longo J; Kaveri SV; Bélec L
    Clin Vaccine Immunol; 2008 May; 15(5):872-84. PubMed ID: 18353923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1.
    Bouhlal H; Hocini H; Quillent-Grégoire C; Donkova V; Rose S; Amara A; Longhi R; Haeffner-Cavaillon N; Beretta A; Kaveri SV; Kazatchkine MD
    J Immunol; 2001 Jun; 166(12):7606-11. PubMed ID: 11390517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1.
    Bouhlal H; Latry V; Requena M; Aubry S; Kaveri SV; Kazatchkine MD; Belec L; Hocini H
    J Immunol; 2005 Jun; 174(11):7202-9. PubMed ID: 15905565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
    Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
    J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract.
    Hladik F; Lentz G; Akridge RE; Peterson G; Kelley H; McElroy A; McElrath MJ
    J Virol; 1999 Jul; 73(7):5833-42. PubMed ID: 10364335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.
    Yi Y; Isaacs SN; Williams DA; Frank I; Schols D; De Clercq E; Kolson DL; Collman RG
    J Virol; 1999 Sep; 73(9):7117-25. PubMed ID: 10438797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages.
    Münch J; Ständker L; Pöhlmann S; Baribaud F; Papkalla A; Rosorius O; Stauber R; Sass G; Heveker N; Adermann K; Escher S; Klüver E; Doms RW; Forssmann WG; Kirchhoff F
    Antimicrob Agents Chemother; 2002 Apr; 46(4):982-90. PubMed ID: 11897579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lupane-type triterpene 30-oxo-calenduladiol is a CCR5 antagonist with anti-HIV-1 and anti-chemotactic activities.
    Barroso-González J; El Jaber-Vazdekis N; García-Expósito L; Machado JD; Zárate R; Ravelo ÁG; Estévez-Braun A; Valenzuela-Fernández A
    J Biol Chem; 2009 Jun; 284(24):16609-16620. PubMed ID: 19386595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
    Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D
    J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
    Rana S; Besson G; Cook DG; Rucker J; Smyth RJ; Yi Y; Turner JD; Guo HH; Du JG; Peiper SC; Lavi E; Samson M; Libert F; Liesnard C; Vassart G; Doms RW; Parmentier M; Collman RG
    J Virol; 1997 Apr; 71(4):3219-27. PubMed ID: 9060685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.
    Requena M; Bouhlal H; Nasreddine N; Saidi H; Gody JC; Aubry S; Grésenguet G; Kazatchkine MD; Sekaly RP; Bélec L; Hocini H
    Immunology; 2008 Apr; 123(4):508-18. PubMed ID: 17999675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1.
    Tuttle DL; Harrison JK; Anders C; Sleasman JW; Goodenow MM
    J Virol; 1998 Jun; 72(6):4962-9. PubMed ID: 9573265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies.
    Ganesh L; Leung K; Loré K; Levin R; Panet A; Schwartz O; Koup RA; Nabel GJ
    J Virol; 2004 Nov; 78(21):11980-7. PubMed ID: 15479838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies.
    Saidi H; Eslahpazir J; Carbonneil C; Carthagena L; Requena M; Nassreddine N; Belec L
    J Immunol; 2006 Oct; 177(8):5540-9. PubMed ID: 17015741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.